Background Racial and ethnic disparities in infectious disease burden have been reported in the USA and globally, most recently during the COVID-19 pandemic. It remains unclear whether such ...

Introduction Burden of non-communicable diseases (NCDs) continues to rise in low- and middle-income countries like Kenya. People with HIV (PWH) may be at greater risk for obesity and NCDs. National ...

We sought to assess the feasibility of mainstreaming balanced energy protein supplementation, a maternal nutrition intervention, into Bangladesh’s routine antenatal care system in tandem with an ...

Introduction Typhoid fever is one of the most common bacterial causes of acute febrile illness in the developing world, with an estimated 10.9 million new cases and 116.8 thousand deaths in 2017.

War has devastating consequences on healthcare, with attacks becoming normalised and health weaponised. The scholarship emphasises the longterm human toll, the need for accountability, humanitarian ...

Background In 2012, the WHO issued a policy recommendation for the use of seasonal malaria chemoprevention (SMC) to children 3–59 months in areas of highly seasonal malaria transmission. Clinical ...

Antimicrobial resistance (AMR) refers to the ability of microbes—bacteria, viruses, fungi and parasites—to survive exposure to drugs that previously cleared them. Mostly, assessments of AMR in ...

In this commentary, we provide a snapshot of the state of quality improvement (QI) and patient safety in Georgia and introduce the Georgia Health Quality Forum (GHQF), a volunteer initiative to ...

Introduction High prices for insulin pose a barrier to treatment for people living with diabetes, with an estimated 50% of 100 million patients needing insulin lacking reliable access. As insulin ...

Introduction The effects of healthcare-related inequalities are most evident in low-resource settings. Such settings are often not explicitly defined, and umbrella terms which are easier to ...

Introduction As countries approach the UNAIDS 95-95-95 targets, there is a need for innovative and cost-saving HIV testing approaches that can increase testing coverage in hard-to-reach populations.

Why do sickle cell disorders (SCDs) remain a low priority on the global child health agenda when a child dies from the condition every three seconds globally? Why are more resources not invested to ...